1. Home
  2. PLRX

PLRX

Pliant Therapeutics Inc.

Logo Pliant Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Founded: 2015 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 871.7M IPO Year: 2020
Target Price: $49.38 AVG Volume (30 days): 381.4K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.75 EPS Growth: N/A
52 Week Low/High: $12.61 - $30.85 Next Earning Date: 05-07-2024
Revenue: $1,580,000 Revenue Growth: -83.69%
Revenue Growth (this year): -57.52% Revenue Growth (next year): 331.94%

Share on Social Networks: